Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2018 Aug 1;29(8):1877.
doi: 10.1093/annonc/mdy204.

Reporting of HRQoL results from the PALOMA-2 trial: Relevant data are still missing

Affiliations
Comment

Reporting of HRQoL results from the PALOMA-2 trial: Relevant data are still missing

T Kaiser et al. Ann Oncol. .
No abstract available

PubMed Disclaimer

Comment in

Comment on

References

    1. Rugo HS, Diéras V, Gelmon KA. et al. Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial. Ann Oncol 2018; 29(4): 888–894. - PMC - PubMed
    1. Finn RS, Martin M, Rugo HS. et al. Palbociclib and letrozole in advanced breast cancer. N Engl J Med 2016; 375(20): 1925–1963. - PubMed
    1. Pfizer Pharma GmbH. Dossier zur Nutzenbewertung gemäss § 35a SGB V: Palbociclib (Ibrance®); Modul 4A: Medizinischer Nutzen und medizinischer Zusatznutzen, Patientengruppen mit therapeutisch bedeutsamem Zusatznutzen. Stand: 22.11.2016. https://www.g-ba.de/downloads/92-975-1744/2016-11-22_Palbociclib_Modul4A... (20 March 2018, date last accessed).
    1. Institute for Quality and Efficiency in Health Care. Palbociclib (breast cancer) – benefit assessment according to §35a Social Code Book V. Published online 1 March 2017. https://www.iqwig.de/en/projects-results/projects/drug-assessment/a16-74... (20 March 2018, date last accessed).
    1. FACIT. FACT-B Scoring & Interpretation Materials. http://www.facit.org/FACITOrg/Questionnaires (20 March 2018, date last accessed).